CoChat
Sign Up
Cited by 36

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives

Biţă, Andrei, Scorei, Ion Romulus, Ciocîlteu, Maria Viorica, Nicolaescu, Oana Elena, Pîrvu, Andreea Silvia, Bejenaru, Ludovic Everard, Rău, Gabriela, Bejenaru, Cornelia, Radu, Antonia, Neamţu, Johny, Mogoşanu, George Dan, Benner, Steven A.·2023·Molecules
DOI 10.3390/molecules28166078PMC PMC10459282
Open this paper in CoChat — free account

Abstract

Many studies have suggested that the oxidized form of nicotinamide adenine dinucleotide (NAD+) is involved in an extensive spectrum of human pathologies, including neurodegenerative disorders, cardiomyopathy, obesity, and diabetes. Further, healthy aging and longevity appear to be closely related to NAD+ and its related metabolites, including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). As a dietary supplement, NR appears to be well tolerated, having better pharmacodynamics and greater potency. Unfortunately, NR is a reactive molecule, often unstable during its manufacturing, transport, and storage. Recently, work related to prebiotic chemistry discovered that NR borate is considerably more stable than NR itself. However, immediately upon consumption, the borate dissociates from the NR borate and is lost in the body through dilution and binding to other species, notably carbohydrates such as fructose and glucose. The NR left behind is expected to behave pharmacologically in ways identical to NR itself. This review provides a comprehensive summary (through Q1 of 2023) of the literature that makes the case for the consumption of NR as a dietary supplement. It then summarizes the challenges of delivering quality NR to consumers using standard synthesis, manufacture, shipping, and storage approaches. It concludes by outlining the advantages of NR borate in these processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules28166078

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent global research underscores bidirectional interactions between gut microbiota and cellular senescence, with microbiome-focused therapeutics demonstrating potential to promote healthier aging.

    “Recent global research underscores the bidirectional interactions between gut microbiota and cellular senescence, with microbiome-focused therapeutics demonstrating potential to promote healthier aging98.”

    From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [98]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 224

  1. Dollerup, 2018, A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: Safety, insulin-sensitivity, and lipid-mobilizing effects, Am. J. Clin. Nutr., 108, 343, 10.1093/ajcn/nqy132 · DOI · Paper page
  2. Mehmel, M., Jovanović, N., and Spitz, U. (2020). Nicotinamide riboside—The current state of research and therapeutic uses. Nutrients, 12. · DOI
  3. Gilbert, 1986, Origin of life: The RNA world, Nature, 319, 618, 10.1038/319618a0 · DOI · Paper page
  4. Chi, 2013, Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection, Curr. Opin. Clin. Nutr. Metab. Care, 16, 657, 10.1097/MCO.0b013e32836510c0 · DOI
  5. Martens, 2018, Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults, Nat. Commun., 9, 1286, 10.1038/s41467-018-03421-7 · DOI · Paper page
  6. Lee, H.J., and Yang, S.J. (2019). Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice. Int. J. Mol. Sci., 20. · DOI
  7. Bogan, 2008, Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor vitamins in human nutrition, Annu. Rev. Nutr., 28, 115, 10.1146/annurev.nutr.28.061807.155443 · DOI · Paper page
  8. Belenky, P., Stebbins, R., Bogan, K.L., Evans, C.R., and Brenner, C. (2011). Nrt1 and Tna1-independent export of NAD+ precursor vitamins promotes NAD+ homeostasis and allows engineering of vitamin production. PLoS ONE, 6. · DOI
  9. Bieganowski, 2004, Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss–Handler independent route to NAD+ in fungi and humans, Cell, 117, 495, 10.1016/S0092-8674(04)00416-7 · DOI · Paper page
  10. Schmidt, 2019, Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter, Nat. Metab., 1, 660, 10.1038/s42255-019-0085-0 · DOI
  11. Canto, C. (2022). NAD+ precursors: A questionable redundancy. Metabolites, 12. · DOI
  12. Auwerx, 2011, NAD+ as a signaling molecule modulating metabolism, Cold Spring Harb. Symp. Quant. Biol., 76, 291, 10.1101/sqb.2012.76.010439 · DOI
  13. Zhang, 2018, Regulatory effects of NAD+ metabolic pathways on sirtuin activity, Prog. Mol. Biol. Transl. Sci., 154, 71, 10.1016/bs.pmbts.2017.11.012 · DOI
  14. Okabe, 2019, Implications of altered NAD metabolism in metabolic disorders, J. Biomed. Sci., 26, 34, 10.1186/s12929-019-0527-8 · DOI · Paper page
  15. Buonvicino, 2021, SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure, J. Biol. Chem., 297, 100855, 10.1016/j.jbc.2021.100855 · DOI
  16. Carpi, 2018, Simultaneous quantification of nicotinamide mononucleotide and related pyridine compounds in mouse tissues by UHPLC–MS/MS, Sep. Sci. Plus, 1, 22, 10.1002/sscp.201700024 · DOI
  17. Demarest, 2019, NAD+ metabolism in aging and cancer, Annu. Rev. Cancer Biol., 3, 105, 10.1146/annurev-cancerbio-030518-055905 · DOI
  18. Yang, 2007, Syntheses of nicotinamide riboside and derivatives: Effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells, J. Med. Chem., 50, 6458, 10.1021/jm701001c · DOI
  19. Houtkooper, 2012, The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity, Cell Metab., 15, 838, 10.1016/j.cmet.2012.04.022 · DOI · Paper page
  20. Gong, 2013, Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models, Neurobiol. Aging, 34, 1581, 10.1016/j.neurobiolaging.2012.12.005 · DOI · Paper page
  21. Conlon, 2022, A systems-approach to NAD+ restoration, Biochem. Pharmacol., 198, 114946, 10.1016/j.bcp.2022.114946 · DOI
  22. Sharma, C., Donu, D., and Cen, Y. (2022). Emerging role of nicotinamide riboside in health and diseases. Nutrients, 14. · DOI
  23. Helman, 2023, Importance of NAD+ anabolism in metabolic, cardiovascular and neurodegenerative disorders, Drugs Aging, 40, 33, 10.1007/s40266-022-00989-0 · DOI
  24. Fang, 2022, A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation, Biomed. Pharmacother., 150, 113071, 10.1016/j.biopha.2022.113071 · DOI
  25. She, 2021, Pharmacology and potential implications of nicotinamide adenine dinucleotide precursors, Aging Dis., 12, 1879, 10.14336/AD.2021.0523 · DOI
  26. Belenky, 2007, NAD+ metabolism in health and disease, Trends Biochem. Sci., 32, 12, 10.1016/j.tibs.2006.11.006 · DOI
  27. Yoshino, 2018, NAD+ intermediates: The biology and therapeutic potential of NMN and NR, Cell Metab., 27, 513, 10.1016/j.cmet.2017.11.002 · DOI · Paper page
  28. Stock, 2023, Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo, Geroscience, 2023, 1
  29. Hong, 2018, Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis, Free Radic. Biol. Med., 123, 125, 10.1016/j.freeradbiomed.2018.05.073 · DOI
  30. Wu, 2022, Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes, J. Clin. Invest., 132, e139828, 10.1172/JCI139828 · DOI
  31. Zhang, 2022, Nicotinamide riboside relieves the severity of experimental necrotizing enterocolitis by regulating endothelial function via eNOS deacetylation, Free Radic. Biol. Med., 184, 218, 10.1016/j.freeradbiomed.2022.04.008 · DOI · Paper page
  32. Fan, 2022, Study on the protective effect and mechanism of nicotinamide riboside on lung injury in paraquat intoxicated mice, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 40, 561
  33. Selli, 2023, Nicotinamide riboside preserves ovarian injury in experimental sepsis model in rats, Eurasian J. Med., 55, 128
  34. DiNicolantonio, 2022, Nutraceutical activation of Sirt1: A review, Open Heart, 9, e002171, 10.1136/openhrt-2022-002171 · DOI · Paper page
  35. Cheng, 2022, Acute treatment with nicotinamide riboside chloride reduces hippocampal damage and preserves the cognitive function of mice with ischemic injury, Neurochem. Res., 47, 2244, 10.1007/s11064-022-03610-3 · DOI
  36. Lenherr, 2021, Co-therapy with S-adenosylmethionine and nicotinamide riboside improves T-cell survival and function in Arts syndrome (PRPS1 deficiency), Mol. Genet. Metab. Rep., 26, 100709, 10.1016/j.ymgmr.2021.100709 · DOI
  37. Kodali, 2023, Pathophysiological basis and promise of experimental therapies for Gulf War Illness, a chronic neuropsychiatric syndrome in veterans, Psychopharmacology, 240, 673, 10.1007/s00213-023-06319-5 · DOI
  38. Joshi, 2020, Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model, Neurotoxicology, 79, 84, 10.1016/j.neuro.2020.04.006 · DOI
  39. Jiang, 2020, Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression, Food Funct., 11, 378, 10.1039/C9FO01780A · DOI · Paper page
  40. Vaur, 2017, Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration, FASEB J., 31, 5440, 10.1096/fj.201700221RR · DOI
  41. Kitaoka, 2020, Axonal protection by nicotinamide riboside via SIRT1-autophagy pathway in TNF-induced optic nerve degeneration, Mol. Neurobiol., 57, 4952, 10.1007/s12035-020-02063-5 · DOI
  42. Chen, 2021, Nicotinamide riboside and metformin ameliorate mitophagy defect in induced pluripotent stem cell-derived astrocytes with POLG mutations, Front. Cell Dev. Biol., 9, 737304, 10.3389/fcell.2021.737304 · DOI
  43. Sun, 2023, NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency, Cell Rep., 42, 112372, 10.1016/j.celrep.2023.112372 · DOI
  44. Yang, 2021, NAD+ supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy, Aging Cell, 20, e13329, 10.1111/acel.13329 · DOI
  45. Veenhuis, 2021, Nicotinamide riboside improves ataxia scores and immunoglobulin levels in ataxia telangiectasia, Mov. Disord., 36, 2951, 10.1002/mds.28788 · DOI
  46. Steinbruecker, 2022, Nicotinamide riboside for ataxia telangiectasia: Report of an early treated individual, Neuropediatrics, 54, 78
  47. Gerasimenko, 2020, Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder, Sci. Rep., 10, 10035, 10.1038/s41598-019-57236-7 · DOI
  48. Gerasimenko, 2023, Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice, Front. Immunol., 14, 1166609, 10.3389/fimmu.2023.1166609 · DOI
  49. Harlan, 2020, Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models, Exp. Neurol., 327, 113219, 10.1016/j.expneurol.2020.113219 · DOI
  50. Zhou, 2020, Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1G93A mice, Int. J. Biol. Sci., 16, 284, 10.7150/ijbs.38487 · DOI
  51. Obrador, 2021, Nicotinamide riboside and pterostilbene cooperatively delay motor neuron failure in ALS SOD1G93A mice, Mol. Neurobiol., 58, 1345, 10.1007/s12035-020-02188-7 · DOI
  52. Freeberg, K.A., Udovich, C.A.C., Martens, C.R., Seals, D.R., and Craighead, D.H. (2023). Dietary supplementation with NAD+-boosting compounds in humans: Current knowledge and future directions. J. Gerontol. A Biol. Sci. Med. Sci., glad106. · DOI
  53. Han, 2020, Nicotinamide riboside protects noise-induced hearing loss by recovering the hair cell ribbon synapses, Neurosci. Lett., 725, 134910, 10.1016/j.neulet.2020.134910 · DOI
  54. Okur, 2020, Short-term NAD+ supplementation prevents hearing loss in mouse models of Cockayne syndrome, NPJ Aging Mech. Dis., 6, 1, 10.1038/s41514-019-0040-z · DOI
  55. Hamity, 2017, Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats, Pain, 158, 962, 10.1097/j.pain.0000000000000862 · DOI
  56. Hamity, 2022, Nicotinamide riboside alleviates corneal and somatic hypersensitivity induced by paclitaxel in male rats, Invest. Ophthalmol. Vis. Sci., 63, 38, 10.1167/iovs.63.1.38 · DOI
  57. Andrei, 2021, NAD+ metabolism and retinal degeneration (Review), Exp. Ther. Med., 22, 670, 10.3892/etm.2021.10102 · DOI
  58. Zhang, X., Zhang, N., Chrenek, M.A., Girardot, P.E., Wang, J., Sellers, J.T., Geisert, E.E., Brenner, C., Nickerson, J.M., and Boatright, J.H. (2021). Systemic treatment with nicotinamide riboside is protective in two mouse models of retinal ganglion cell damage. Pharmaceutics, 13. · DOI
  59. Zhang, 2020, Systemic treatment with nicotinamide riboside is protective in a mouse model of light-induced retinal degeneration, Invest. Ophthalmol. Vis. Sci., 61, 47, 10.1167/iovs.61.10.47 · DOI
  60. Leung, 2022, Nicotinamide riboside as a neuroprotective therapy for glaucoma: Study protocol for a randomized, double-blind, placebo-control trial, Trials, 23, 45, 10.1186/s13063-021-05968-1 · DOI
  61. Silva, 2023, The use of nicotinamide and nicotinamide riboside as an adjunct therapy in the treatment of glaucoma, Eur. J. Ophthalmol., 2023, 11206721231161101
  62. Zhou, 2021, Protective effects of nicotinamide riboside on H2O2-induced oxidative damage in lens epithelial cells, Curr. Eye Res., 46, 961, 10.1080/02713683.2020.1855662 · DOI
  63. Pang, 2021, Aberrant NAD+ metabolism underlies Zika virus-induced microcephaly, Nat. Metab., 3, 1109, 10.1038/s42255-021-00437-0 · DOI
  64. Matasic, 2018, Emerging potential benefits of modulating NAD+ metabolism in cardiovascular disease, Am. J. Physiol. Heart Circ. Physiol., 314, H839, 10.1152/ajpheart.00409.2017 · DOI
  65. Ahmad, 2020, Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling, Biochim. Biophys. Acta Mol. Basis Dis., 1866, 165609, 10.1016/j.bbadis.2019.165609 · DOI
  66. Rotllan, 2022, NAD+-increasing strategies to improve cardiometabolic health?, Front. Endocrinol., 12, 815565, 10.3389/fendo.2021.815565 · DOI
  67. Liu, Y., Huang, Y., Xu, C., An, P., Luo, Y., Jiao, L., Luo, J., and Li, Y. (2022). Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases. Int. J. Mol. Sci., 23. · DOI
  68. Stein, 2020, Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction, Life Sci., 263, 118596, 10.1016/j.lfs.2020.118596 · DOI
  69. Liu, 2022, Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice, J. Mol. Cell Cardiol., 165, 76, 10.1016/j.yjmcc.2021.12.015 · DOI
  70. Ma, 2021, Nicotinamide riboside alleviates cardiac dysfunction and remodeling in pressure overload cardiac hypertrophy, Oxid. Med. Cell. Longev., 2021, 5546867, 10.1155/2021/5546867 · DOI
  71. Zhang, 2019, NAD+ repletion inhibits the endothelial-to-mesenchymal transition induced by TGF-β in endothelial cells through improving mitochondrial unfolded protein response, Int. J. Biochem. Cell Biol., 117, 105635, 10.1016/j.biocel.2019.105635 · DOI
  72. Pool, L., Knops, P., Manintveld, O.C., Brugts, J.J., Theuns, D.A.M.J., Brundel, B.J.J.M., and de Groot, N.M.S. (2022). The HF-AF ENERGY Trial: Nicotinamide riboside for the treatment of atrial fibrillation in heart failure patients. Cardiovasc. Drugs Ther., 1–6. · DOI
  73. Zhou, 2020, Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure, J. Clin. Invest., 130, 6054, 10.1172/JCI138538 · DOI
  74. Wang, 2022, Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction, JACC Basic Transl. Sci., 7, 1183, 10.1016/j.jacbts.2022.06.012 · DOI
  75. Oller, 2022, Rewiring vascular metabolism prevents sudden death due to aortic ruptures—Brief report, Arterioscler. Thromb. Vasc. Biol., 42, 462, 10.1161/ATVBAHA.121.317346 · DOI
  76. Shahzadi, 2022, Nicotinamide riboside kinase-2 inhibits JNK pathway and limits dilated cardiomyopathy in mice with chronic pressure overload, Clin. Sci., 136, 181, 10.1042/CS20210964 · DOI
  77. Zheng, 2019, Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity, Clin. Sci., 133, 1505, 10.1042/CS20181022 · DOI
  78. Podyacheva, E., and Toropova, Y. (2021). Nicotinamide riboside for the prevention and treatment of doxorubicin cardiomyopathy. Opportunities and prospects. Nutrients, 13. · DOI
  79. Podyacheva, E., Semenova, N.Y., Zinserling, V.A., Mukhametdinova, D., Goncharova, I., Zelinskaya, I., Sviridov, E., Martynov, M., Osipova, S., and Toropova, Y. (2022). Intravenous nicotinamide riboside administration has a cardioprotective effect in chronic doxorubicin-induced cardiomyopathy. Int. J. Mol. Sci., 23. · DOI
  80. Marzook, 2023, Nicotinamide riboside kinase-2 regulates metabolic adaptation in the ischemic heart, J. Mol. Med., 101, 311, 10.1007/s00109-023-02296-6 · DOI
  81. Nie, 2021, Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability and attenuated cardiac ischemia/reperfusion injury in mice, Drug Deliv., 28, 433, 10.1080/10717544.2021.1886198 · DOI
  82. Xiao, 2021, Cardioprotective properties of known agents in rat ischemia-reperfusion model under clinically relevant conditions: Only the NAD precursor nicotinamide riboside reduces infarct size in presence of fentanyl, midazolam and cangrelor, but not propofol, Front. Cardiovasc. Med., 8, 712478, 10.3389/fcvm.2021.712478 · DOI
  83. Toropova, 2018, Nicotinamide riboside has protective effects in a rat model of mesenteric ischaemia–reperfusion, Int. J. Exp. Pathol., 99, 304, 10.1111/iep.12302 · DOI
  84. Mateuszuk, 2020, Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside, Biochem. Pharmacol., 178, 114019, 10.1016/j.bcp.2020.114019 · DOI · Paper page
  85. Mukherjee, 2017, Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration, Hepatology, 65, 616, 10.1002/hep.28912 · DOI
  86. Dall, 2019, Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity, J. Biol. Chem., 294, 13304, 10.1074/jbc.RA118.006756 · DOI
  87. Lee, 2019, Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes, Nutr. Res. Pr., 13, 3, 10.4162/nrp.2019.13.1.3 · DOI
  88. Fan, 2018, Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance, Biochem. Biophys. Res. Commun., 500, 476, 10.1016/j.bbrc.2018.04.107 · DOI
  89. Han, 2019, Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice, PeerJ, 7, e7568, 10.7717/peerj.7568 · DOI
  90. Bock, 2020, Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD), Biochem. Pharmacol., 175, 113905, 10.1016/j.bcp.2020.113905 · DOI
  91. Dall, 2021, Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes, J. Biol. Chem., 297, 101388, 10.1016/j.jbc.2021.101388 · DOI
  92. Quesada-Vázquez, S., Bone, C., Saha, S., Triguero, I., Colom-Pellicer, M., Aragonès, G., Hildebrand, F., Del Bas, J.M., Caimari, A., and Beraza, N. (2022). Microbiota dysbiosis and gut barrier dysfunction associated with non-alcoholic fatty liver disease are modulated by a specific metabolic cofactors’ combination. Int. J. Mol. Sci., 23. · DOI
  93. Dellinger, R.W., Holmes, H.E., Hu-Seliger, T., Butt, R.W., Harrison, S.A., Mozaffarian, D., Chen, O., and Guarente, L. (2022). Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial. Hepatology. · DOI
  94. Pham, 2019, Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 2451, 10.1016/j.bbadis.2019.06.009 · DOI
  95. Jiang, 2019, Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway, Life Sci., 225, 20, 10.1016/j.lfs.2019.03.064 · DOI
  96. Wang, 2018, Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway, Redox Biol., 17, 89, 10.1016/j.redox.2018.04.006 · DOI
  97. Yau, 2023, Nicotinamide riboside rescues dysregulated glycolysis and fatty acid β-oxidation in a human hepatic cell model of citrin deficiency, Human Mol. Genet., 32, 1922, 10.1093/hmg/ddad018 · DOI
  98. Lee, 2022, Activation of TCA cycle restrains virus-metabolic hijacking and viral replication in mouse hepatitis virus-infected cells, Cell Biosci., 12, 7, 10.1186/s13578-021-00740-z · DOI
  99. Parikh, 2019, Metabolic stress resistance in acute kidney injury: Evidence for a PPAR-gamma-coactivator-1 alpha-nicotinamide adenine dinucleotide pathway, Nephron, 143, 184, 10.1159/000500168 · DOI
  100. Simic, P., Vela Parada, X.F., Parikh, S.M., Dellinger, R., Guarente, L.P., and Rhee, E.P. (2020). Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): A randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI. BMC Nephrol., 21. · DOI
  101. Lin, 2021, Nicotinamide retains Klotho expression and ameliorates rhabdomyolysis-induced acute kidney injury, Nutrition, 91–92, 111376, 10.1016/j.nut.2021.111376 · DOI
  102. Piedrafita, 2021, The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury, Clin. Kidney J., 14, 2490, 10.1093/ckj/sfab050 · DOI
  103. Carriazo, 2021, Nicotinamide and acute kidney injury, Clin. Kidney J., 14, 2453, 10.1093/ckj/sfab173 · DOI
  104. Pezzotta, A., Perico, L., Morigi, M., Corna, D., Locatelli, M., Zoja, C., Benigni, A., Remuzzi, G., and Imberti, B. (2022). Low nephron number induced by maternal protein restriction is prevented by nicotinamide riboside supplementation depending on sirtuin 3 activation. Cells, 11. · DOI
  105. Morevati, M., Egstrand, S., Nordholm, A., Mace, M.L., Andersen, C.B., Salmani, R., Olgaard, K., and Lewin, E. (2021). Effect of NAD+ boosting on kidney ischemia–reperfusion injury. PLoS ONE, 16. · DOI
  106. Doke, 2023, NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury, Nat. Metab., 5, 414, 10.1038/s42255-023-00761-7 · DOI
  107. Ahmadi, 2023, Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease, JCI Insight, 8, e167274, 10.1172/jci.insight.167274 · DOI
  108. Fletcher, 2017, Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells, Mol. Metab., 6, 819, 10.1016/j.molmet.2017.05.011 · DOI
  109. Sonntag, 2022, Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration, Front. Cell Dev. Biol., 10, 1049653, 10.3389/fcell.2022.1049653 · DOI
  110. Doig, 2020, Induction of the nicotinamide riboside kinase NAD+ salvage pathway in a model of sarcoplasmic reticulum dysfunction, Skelet. Muscle, 10, 5, 10.1186/s13395-019-0216-z · DOI
  111. Damgaard, 2022, Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity, iScience, 25, 103863, 10.1016/j.isci.2022.103863 · DOI
  112. Remie, 2020, Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans, Am. J. Clin. Nutr., 112, 413, 10.1093/ajcn/nqaa072 · DOI · Paper page
  113. Custodero, 2020, Nicotinamide riboside—A missing piece in the puzzle of exercise therapy for older adults?, Exp. Gerontol., 137, 110972, 10.1016/j.exger.2020.110972 · DOI
  114. Campelj, 2022, NAD+ therapeutics and skeletal muscle adaptation to exercise in humans, Sports Med., 52, 91, 10.1007/s40279-022-01772-2 · DOI
  115. Stocks, 2021, Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise, J. Physiol., 599, 1513, 10.1113/JP280825 · DOI
  116. Song, M., Armenian, S.H., Bhandari, R., Lee, K., Ness, K., Putt, M., Lindenfeld, L., Manoukian, S., Wade, K., and Dedio, A. (2022). Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: A randomized controlled trial {1}. BMC Cancer, 22. · DOI
  117. Kourtzidis, 2016, The NAD+ precursor nicotinamide riboside decreases exercise performance in rats, J. Int. Soc. Sports Nutr., 13, 32, 10.1186/s12970-016-0143-x · DOI
  118. Kourtzidis, 2018, Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance, Exp. Physiol., 103, 1357, 10.1113/EP086964 · DOI
  119. Deloux, 2018, Aged nicotinamide riboside kinase 2 deficient mice present an altered response to endurance exercise training, Front. Physiol., 9, 1290, 10.3389/fphys.2018.01290 · DOI
  120. Moon, 2018, Rejuvenating aged hematopoietic stem cells through improvement of mitochondrial function, Ann. Lab. Med., 38, 395, 10.3343/alm.2018.38.5.395 · DOI
  121. Schaefer, 2022, Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice, Mol. Metab., 64, 101560, 10.1016/j.molmet.2022.101560 · DOI
  122. Lapatto, 2023, Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study, Sci. Adv., 9, eadd5163, 10.1126/sciadv.add5163 · DOI
  123. Perez-Sanchez, C., Escudero-Contreras, A., Cerdó, T., Sánchez-Mendoza, L.M., Llamas-Urbano, A., Arias-de la Rosa, I., Pérez-Rodriguez, M., Muñoz-Barrera, L., Abalos-Aguilera, M.D.C., and Barbarroja, N. (2023). Preclinical characterization of pharmacological NAD+ boosting as a promising therapeutic approach in rheumatoid arthritis. Arthritis Rheumatol. · DOI
  124. Gonzalez, 2020, In ovo feeding of nicotinamide riboside affects broiler pectoralis major muscle development, Transl. Anim. Sci., 4, txaa126, 10.1093/tas/txaa126 · DOI
  125. Xu, 2021, The effects of in ovo nicotinamide riboside dose on broiler myogenesis, Poult. Sci., 100, 100926, 10.1016/j.psj.2020.12.024 · DOI
  126. Xu, 2022, Effects of in ovo injection of nicotinamide riboside on high-yield broiler myogenesis, J. Anim. Sci., 100, skac203, 10.1093/jas/skac203 · DOI
  127. Sambeat, 2019, Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage, Nat. Commun., 10, 4291, 10.1038/s41467-019-12262-x · DOI
  128. Igarashi, 2019, NAD+ supplementation rejuvenates aged gut adult stem cells, Aging Cell, 18, e12935, 10.1111/acel.12935 · DOI · Paper page
  129. Cartwright, 2021, Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity, J. Endocrinol., 251, 111, 10.1530/JOE-21-0123 · DOI
  130. Sauve, 2022, Metabolic disease, NAD metabolism, nicotinamide riboside, and the gut microbiome: Connecting the dots from the gut to physiology, mSystems, 7, e0122321, 10.1128/msystems.01223-21 · DOI
  131. Kolba, N., Zarei, A., Cheng, J., Agarwal, N., Dadmohammadi, Y., Khazdooz, L., Abbaspourrad, A., and Tako, E. (2022). Alterations in intestinal brush border membrane functionality and bacterial populations following intra-amniotic administration (Gallus gallus) of nicotinamide riboside and its derivatives. Nutrients, 14. · DOI
  132. Peluso, 2023, Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans, NPJ Aging, 9, 7, 10.1038/s41514-023-00106-4 · DOI
  133. Kim, 2022, Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice, J. Nutr. Biochem., 107, 109058, 10.1016/j.jnutbio.2022.109058 · DOI
  134. Longo, 2023, Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet-induced obesity in rats, Nutrition, 110, 112019, 10.1016/j.nut.2023.112019 · DOI
  135. Yu, 2020, Effect of nicotinamide riboside on lipid metabolism and gut microflora–bile acid axis in alcohol-exposed mice, Food Sci. Nutr., 9, 429, 10.1002/fsn3.2007 · DOI
  136. Crisol, 2018, Nicotinamide riboside induces a thermogenic response in lean mice, Life Sci., 211, 1, 10.1016/j.lfs.2018.09.015 · DOI
  137. Crisol, 2020, NAD+ precursor increases aerobic performance in mice, Eur. J. Nutr., 59, 2427, 10.1007/s00394-019-02089-z · DOI
  138. Williams, 2021, Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome, iScience, 25, 103635, 10.1016/j.isci.2021.103635 · DOI
  139. Serrano, A., Palou, A., Bonet, M.L., and Ribot, J. (2022). Nicotinamide riboside supplementation to suckling male mice improves lipid and energy metabolism in skeletal muscle and liver in adulthood. Nutrients, 14. · DOI
  140. Stein, 2021, Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction: A preliminary investigation, Front. Nutr., 8, 648893, 10.3389/fnut.2021.648893 · DOI
  141. Shi, W., Hegeman, M.A., Doncheva, A., Bekkenkamp-Grovenstein, M., de Boer, V.C.J., and Keijer, J. (2019). High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet. Nutrients, 11. · DOI
  142. Shi, 2019, Transcriptional response of white adipose tissue to withdrawal of vitamin B3, Mol. Nutr. Food Res., 63, e1801100, 10.1002/mnfr.201801100 · DOI
  143. Quesada-Vázquez, S., Antolín, A., Colom-Pellicer, M., Aragonès, G., Herrero, L., Del Bas, J.M., Caimari, A., and Escoté, X. (2022). Reduction of obesity and insulin resistance through dual targeting of VAT and BAT by a novel combination of metabolic cofactors. Int. J. Mol. Sci., 23. · DOI
  144. Zhao, 2022, Nicotinamide riboside ameliorates high-fructose-induced lipid metabolism disorder in mice via improving FGF21 resistance in the liver and white adipose tissue, Food Funct., 13, 12400, 10.1039/D2FO01934E · DOI
  145. Serrano, A., Asnani-Kishnani, M., Couturier, C., Astier, J., Palou, A., Landrier, J.F., Ribot, J., and Bonet, M.L. (2020). DNA methylation changes are associated with the programming of white adipose tissue browning features by resveratrol and nicotinamide riboside neonatal supplementations in mice. Nutrients, 12. · DOI
  146. Salic, K., Gart, E., Seidel, F., Verschuren, L., Caspers, M., van Duyvenvoorde, W., Wong, K.E., Keijer, J., Bobeldijk-Pastorova, I., and Wielinga, P.Y. (2019). Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis. Int. J. Mol. Sci., 20. · DOI
  147. Nagy, 2022, Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production, Front. Cell Dev. Biol., 10, 979330, 10.3389/fcell.2022.979330 · DOI
  148. Nascimento, 2021, Nicotinamide riboside enhances in vitro beta-adrenergic brown adipose tissue activity in humans, J. Clin. Endocrinol. Metab., 106, 1437, 10.1210/clinem/dgaa960 · DOI
  149. Dollerup, 2019, Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity, J. Clin. Endocrinol. Metab., 104, 5703, 10.1210/jc.2019-01081 · DOI · Paper page
  150. Chandrasekaran, K., Najimi, N., Sagi, A.R., Yarlagadda, S., Salimian, M., Arvas, M.I., Hedayat, A.F., Kevas, Y., Kadakia, A., and Russell, J.W. (2022). NAD+ precursors repair mitochondrial function in diabetes and prevent experimental diabetic neuropathy. Int. J. Mol. Sci., 23. · DOI
  151. Cercillieux, 2022, Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure, Mol. Metab., 66, 101605, 10.1016/j.molmet.2022.101605 · DOI
  152. Costa, 2023, Nicotinamide riboside improves enteric neuropathy in streptozocin-induced diabetic rats through myenteric plexus neuroprotection, Dig. Dis. Sci., 68, 2963, 10.1007/s10620-023-07913-5 · DOI
  153. Lee, 2015, Nicotinamide riboside ameliorates hepatic metaflammation by modulating NLRP3 inflammasome in a rodent model of type 2 diabetes, J. Med. Food, 18, 1207, 10.1089/jmf.2015.3439 · DOI
  154. Wang, 2021, Nicotinamide riboside enhances endothelial precursor cell function to promote refractory wound healing through mediating the Sirt1/AMPK pathway, Front. Pharmacol., 12, 671563, 10.3389/fphar.2021.671563 · DOI
  155. Lee, 2023, Dietary supplementation with nicotinamide riboside improves fetal growth under hypoglycemia, J. Nutr. Biochem., 116, 109310, 10.1016/j.jnutbio.2023.109310 · DOI
  156. Chu, 2022, Regulation of NAD+ metabolism in aging and disease, Metabolism, 126, 154923, 10.1016/j.metabol.2021.154923 · DOI
  157. Ji, L.L., and Yeo, D. (2022). Maintenance of NAD+ homeostasis in skeletal muscle during aging and exercise. Cells, 11. · DOI
  158. Gomes, 2013, Declining NAD+ induces a pseudohypoxic state disrupting nuclear–mitochondrial communication during aging, Cell, 155, 1624, 10.1016/j.cell.2013.11.037 · DOI · Paper page
  159. Cercillieux, 2022, Balancing NAD+ deficits with nicotinamide riboside: Therapeutic possibilities and limitations, Cell Mol. Life Sci., 79, 463, 10.1007/s00018-022-04499-5 · DOI
  160. Li, W., Zhou, Y., Pang, N., Hu, Q., Li, Q., Sun, Y., Ding, Y., Gu, Y., Xiao, Y., and Gao, M. (2022). NAD supplement alleviates intestinal barrier injury induced by ethanol via protecting epithelial mitochondrial function. Nutrients, 15. · DOI
  161. Sun, 2021, Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells, Nat. Commun., 12, 2665, 10.1038/s41467-021-22863-0 · DOI
  162. Yoshino, 2011, Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice, Cell Metab., 14, 528, 10.1016/j.cmet.2011.08.014 · DOI · Paper page
  163. Tammaro, 2021, Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice, FASEB J., 35, e21456
  164. Freeberg, 2022, Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in midlife and older adults, Front. Cardiovasc. Med., 9, 881703, 10.3389/fcvm.2022.881703 · DOI
  165. Acklin, 2022, Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation, Neurooncol. Adv., 4, vdac101
  166. Mukherjee, 2021, SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside, JCI Insight, 6, e147193, 10.1172/jci.insight.147193 · DOI
  167. Zhang, 2018, Sirtuin 3 deficiency aggravates contrast-induced acute kidney injury, J. Transl. Med., 16, 313, 10.1186/s12967-018-1690-5 · DOI
  168. Kang, 2021, Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages, Lab. Invest., 101, 1225, 10.1038/s41374-021-00599-1 · DOI
  169. Seldeen, 2021, Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors, Nutrition, 87–88, 111189, 10.1016/j.nut.2021.111189 · DOI
  170. Dolopikou, 2020, Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: A double-blind cross-over study, Eur. J. Nutr., 59, 505, 10.1007/s00394-019-01919-4 · DOI
  171. Grezella, 2018, Effects of senolytic drugs on human mesenchymal stromal cells, Stem Cell Res. Ther., 9, 108, 10.1186/s13287-018-0857-6 · DOI
  172. Delabie, 2020, The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion, Transfusion, 60, 165, 10.1111/trf.15556 · DOI
  173. Harrison, 2021, 17-α-Estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex, Aging Cell, 20, e13328, 10.1111/acel.13328 · DOI
  174. Orlandi, I., Alberghina, L., and Vai, M. (2020). Nicotinamide, nicotinamide riboside and nicotinic acid-emerging roles in replicative and chronological aging in yeast. Biomolecules, 10. · DOI
  175. Odoh, 2022, The role of NAD and NAD precursors on longevity and lifespan modulation in the budding yeast, Saccharomyces cerevisiae, Biogerontology, 23, 169, 10.1007/s10522-022-09958-x · DOI
  176. Braidy, 2014, Mapping NAD+ metabolism in the brain of ageing Wistar rats: Potential targets for influencing brain senescence, Biogerontology, 15, 177, 10.1007/s10522-013-9489-5 · DOI
  177. Reiten, 2021, Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing, Mech. Ageing Dev., 199, 111567, 10.1016/j.mad.2021.111567 · DOI
  178. Braidy, 2020, Can nicotinamide riboside protect against cognitive impairment?, Curr. Opin. Clin. Nutr. Metab. Care, 23, 413, 10.1097/MCO.0000000000000691 · DOI
  179. Brandt, 2022, The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside, Front. Aging, 3, 1005322, 10.3389/fragi.2022.1005322 · DOI
  180. Xie, 2019, Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer’s disease model mice, Metab. Brain Dis., 34, 353, 10.1007/s11011-018-0346-8 · DOI
  181. Larrick, 2021, Modulation of cGAS-STING pathway by nicotinamide riboside in Alzheimer’s disease, Rejuvenation Res., 24, 397, 10.1089/rej.2021.0062 · DOI
  182. Roboon, 2021, Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD, J. Neurochem., 158, 311, 10.1111/jnc.15367 · DOI
  183. Chu, 2022, Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model, Front. Aging Neurosci., 14, 993615, 10.3389/fnagi.2022.993615 · DOI
  184. Ryu, 2022, Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer’s disease, Aging Cell, 21, e13658, 10.1111/acel.13658 · DOI
  185. Yulug, 2023, Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: A randomised, double-blinded, placebo-controlled phase-II trial, Transl. Neurodegener., 12, 4, 10.1186/s40035-023-00336-2 · DOI · Paper page
  186. Li, 2020, Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice, CNS Neurosci. Ther., 26, 438, 10.1111/cns.13276 · DOI
  187. Ivanyuk, 2018, The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease, Cell Rep., 23, 2976, 10.1016/j.celrep.2018.05.009 · DOI · Paper page
  188. Brakedal, 2022, The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease, Cell Metab., 34, 396, 10.1016/j.cmet.2022.02.001 · DOI · Paper page
  189. Vreones, 2023, Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin, Aging Cell, 22, e13754, 10.1111/acel.13754 · DOI
  190. Gaare, 2023, Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease, iScience, 26, 106278, 10.1016/j.isci.2023.106278 · DOI
  191. Pang, N., Hu, Q., Zhou, Y., Xiao, Y., Li, W., Ding, Y., Chen, Y., Ye, M., Pei, L., and Li, Q. (2023). Nicotinamide adenine dinucleotide precursor suppresses hepatocellular cancer progression in mice. Nutrients, 15. · DOI
  192. Park, 2021, Nicotinamide riboside vitamin B3 mitigated C26 adenocarcinoma-induced cancer cachexia, Front. Pharmacol., 12, 665493, 10.3389/fphar.2021.665493 · DOI
  193. Hamity, 2020, Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats, Pain, 161, 2364, 10.1097/j.pain.0000000000001924 · DOI
  194. Kahn, 2022, A narrative review of nicotinamide adenine dinucleotide (NAD)+ intermediates nicotinamide riboside and nicotinamide mononucleotide for keratinocyte carcinoma risk reduction, J. Drugs Dermatol., 21, 1129, 10.36849/JDD.6870 · DOI
  195. Conze, 2016, Safety assessment of nicotinamide riboside, a form of vitamin B3, Human Exp. Toxicol., 35, 1149, 10.1177/0960327115626254 · DOI
  196. Marinescu, 2020, Safety assessment of high-purity, synthetic nicotinamide riboside (NR-E) in a 90-day repeated dose oral toxicity study, with a 28-day recovery arm, Int. J. Toxicol., 39, 307, 10.1177/1091581820927406 · DOI
  197. Sun, 2022, Nicotinamide riboside will play an important role in anti-aging therapy in humans, especially in the face skin anti-aging treatment, Aesthetic. Plast Surg., 46, 192, 10.1007/s00266-021-02335-y · DOI
  198. Ito, 2020, A nonrandomized study of single oral supplementation within the daily tolerable upper level of nicotinamide affects blood nicotinamide and NAD+ levels in healthy subjects, Transl. Med. Aging, 4, 45, 10.1016/j.tma.2020.04.002 · DOI
  199. Ito, 2021, A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects, Transl. Med. Aging, 5, 43, 10.1016/j.tma.2021.09.001 · DOI
  200. Turner, 2021, Safety evaluation for Restorin® NMN, a NAD+ precursor, Front. Pharmacol., 12, 749727, 10.3389/fphar.2021.749727 · DOI

200 of 224 shown

Cited by

Sorted by citations

Metadata

Authors
Biţă, A., Scorei, I. R., Ciocîlteu, M. V., Nicolaescu, O. E., Pîrvu, A. S., Bejenaru, L. E., Rău, G., Bejenaru, C., Radu, A., Neamţu, J., Mogoşanu, G. D., & Benner, S. A.
Venue
Molecules
Publisher
MDPI AG
Published
2023-08-15
Volume
28
Issue
16
Pages
6078
ISSN
1420-3049
DOI
10.3390/molecules28166078
PMC
PMC10459282
Cited by
36
References
30
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • University of Medicine and Pharmacy of Craiova (26/29C, EAR-2213438)
  • US National Science Foundation (26/29C, EAR-2213438)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review